In stark contrast to maximum newly approved medication, Eli Lilly’s Zepsure for chronic weight guyagement wishes little introduction.
Thousands of media stories and social media posts heralded the inside track of Zepsure’s FDA approval in November and however with its availability in pharmacies earlier this month. Upload that to wideer conversations on social media in recent years about GLP-1s and weight reduction, including off-label use of kind 2 diabetes deal withment Mounjaro, which is similar molecule as Zepsure, and it’s no longer surprising that the release is in complete swing.
Liberate this newsletter straight away via changing into a unfastened subscriber.
You’ll get get entry to to unfastened articles every month, plus you’ll be able to customise what newsletters get delivered on your inbox every week, together with breaking information.
